An observational study in Colorectal Cancer, sponsored by Zagazig University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-22.
Sponsored by Zagazig University · Observational
over the past decade colon cancer has emerged as the second most deadly and the third most common type of cancer in the world with increasing incidence in Egypt due to life style and diet change. some research showed relation between colon cancer recurrence and advanced tumor staging. To investigators knowledge, this is the first time to be done in Zagazig University.
Data was collected from records in a retrospective cohort study
5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.
This study's enrollment of 200 is below the median of 250 across 1,226 observational studies indexed under Colorectal Neoplasms.
Browse Colorectal Neoplasms studies →Zagazig University is the lead sponsor of 447 studies on the registry; 75 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
patient with newely diagnosed colorectal cancer were followed up after surgery to detect if there was a recurrence prospectively, while patients with recurrent colorectal cancer were studied retrospectively to find out factors influencing the recurrence
Exclusion Criteria:
resection of bowel segment and re-anastmosis or stoma formation
age
age of patients was obtained from medical records
Time frame: through study completion, an average of 5 years
sex
sex of patients was obtained from medical records
Time frame: through study completion, an average of 5 years
medical disease
co-existing medical disease was obtained from medical records
Time frame: through study completion, an average of 5 years
previous surgery
previous surgical history was obtained from medical records
Time frame: through study completion, an average of 5 years
CEA
value of carcino-embryonic antigen was recorded
Time frame: through study completion, an average of 5 years
tumor grade
tumor grade after resection from pathology report recorded
Time frame: through study completion, an average of 5 years
tumor site
tumor site recorded from operative findings
Time frame: through study completion, an average of 5 years
tumor size
tumor size was measured by length x width in cm from records
Time frame: through study completion, an average of 5 years
surgical margins of resected tumor
safety margins were assessed from pathological examination under microscopy and recorded in pathology reports, it can be free surgical margins ( no tumor cells) or positive surgical margins( presence of tumor cells)
Time frame: through study completion, an average of 5 years
neoadjuvant therapy
history of neoadjuvant therapy before surgery from records obtained
Time frame: through study completion, an average of 5 years
adjuvant therapy
history of adjuvant therapy post operative obtained from records
Time frame: through study completion, an average of 5 years
diet
diet and dietary life style from history
Time frame: through study completion, an average of 5 years
occupation
occupation of the patient at time of surgery and if it was changed
Time frame: through study completion, an average of 5 years
family history
history taking of family history of cancer disease
Time frame: through study completion, an average of 5 years
type of surgery(laparoscopic or open)
type of operation was laparoscopic or open surgery obtained from records
Time frame: through study completion, an average of 5 years
soiling by during surgery
by history from records if there was soiling of the field by tumor cells
Time frame: through study completion, an average of 5 years
hand sewen or stappled anastmosis
if there was bowel re-anastmosis after surgery, it was done using a stappler or hand sewing sutures. this was obtained from operative data in patient records
Time frame: through study completion, an average of 5 years
post operative complications
from records; if there were post operative complication like fecal fistula
Time frame: through study completion, an average of 5 years
site of recurrence
site of tumor recurrence was detected
Time frame: through study completion, an average of 5 years
type of resected tumor
type of tumor was recorded from pathology reports
Time frame: through study completion, an average of 5 years
Plan to share: No — data will be available on demand by contacting the principle investigator
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zagazig University